Simulations Plus Releases Software Update for Better Pharmaceutical Drug Design

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released Version 4.5 of its ClassPharmer software for analysis of chemical libraries and design of new molecular structures.

MORE ON THIS TOPIC